Results of the first call for research into personalised medicine

Data: 2023 01 30
Name Name of the executing authority Project duration in months Total amount of support, EUR
Reflection of EMT processes in liquid biopsies for decision-making in pancreatic cancer treatment LSMU 36 150000.00
Analysis of the free circulating DNA mutation profile in the blood of healthy, atrophic gastritis and gastric cancer patients LSMU 18 60000.00
A study of personalised immunotherapy and local tumour cryotherapy in non-small cell lung cancer patients, assessing changes in peripheral blood T lymphocyte populations and functions LSMUL Kaunas Clinic 36 109070.00
Epigenetic biomarkers for early non-invasive diagnosis of renal tumours and personalised therapy NSI and VU 24 25800.00
Development of model systems for personalised therapy in endometrial cancer VU 36 100000.00
Diagnostic value of eosinophil-specific blood markers in
asthma
LSMU 18 28000.00
Genetic biomarker analysis in patients with squamous cell
laryngeal cancer
LSMU 24 60000.00
Molecular studies of CAR-NK cells in vitro and in vivo VU 36 70000.00
Necrotising enterocolitis of prematurity:
multilevel metagenomic and proteomic biomarkers
Study
LSMU 36 45000.00
An innovative approach to identify signalling pathways in pancreatic cancer and use it to tailor individual therapy with redistributed targeted therapies VU 24 55000.00
Exploring a personalised cardiovascular risk prediction model: using artificial intelligence and epigenetics VU Santaros Clinic 18 59000.00
Multigene marker system for prostate cancer risk detection NVI 12 39300.00
801170.00